<DOC>
	<DOCNO>NCT01867216</DOCNO>
	<brief_summary>The main purpose study determine safety LY2922470 , take oral capsule , twice daily approximately 28 day , participant diabetes . It also aim determine long drug stay body affect blood sugar level . A screening appointment require within 28 day start study follow appointment require approximately 14 day last study dose take .</brief_summary>
	<brief_title>A Study Multiple Doses LY2922470 Participants With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Must male , female become pregnant , type 2 diabetes Have glycated hemoglobin ( HbA1c ) value great equal 6.5 % less equal 11 % screening Do change diabetes treatment ( exercise without metformin ) least 4 week prior screen Have screen body mass index ( BMI ) 18.0 45.0 kilogram per square meter ( kg/m^2 ) Have blood pressure , pulse rate , blood urine laboratory test result acceptable study Are currently participate another clinical study complete one last 30 day Have history significant heart , lung , liver , kidney , stomach brain disease , medical problem may cause increase risk study Have electrocardiogram ( ECG ) read suitable study Are infect hepatitis B hepatitis C Are infected human immunodeficiency virus ( HIV ) Have donate blood equal 500 mL within 56 day first dose drug donate plasma within 7 day first dose provide blood donation within last month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>